Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1486 | 2015 |
New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 854 | 2022 |
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ... Alzheimer's research & therapy 7, 1-20, 2015 | 615 | 2015 |
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease A Brinkmalm, G Brinkmalm, WG Honer, L Frölich, L Hausner, L Minthon, ... Molecular neurodegeneration 9, 1-13, 2014 | 282 | 2014 |
Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study FH Duits, P Martinez‐Lage, C Paquet, S Engelborghs, A Lleo, L Hausner, ... Alzheimer's & Dementia 12 (2), 154-163, 2016 | 234 | 2016 |
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial H Soininen, A Solomon, PJ Visser, SB Hendrix, K Blennow, M Kivipelto, ... The Lancet Neurology 16 (12), 965-975, 2017 | 216 | 2017 |
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 172 | 2021 |
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ... JAMA psychiatry 75 (1), 84-95, 2018 | 166 | 2018 |
Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia L Hausner, M Damian, A Sartorius, L Frölich The Journal of clinical psychiatry 71 (1), 6005, 2010 | 138 | 2010 |
Detection of retinal nerve fiber layer defects in Alzheimer’s disease using SD-OCT R Kromer, N Serbecic, L Hausner, L Froelich, F Aboul-Enein, ... Frontiers in psychiatry 5, 22, 2014 | 130 | 2014 |
Predicting prodromal Alzheimer's disease in subjects with mild cognitive impairment using machine learning classification of multimodal multicenter diffusion‐tensor and … M Dyrba, F Barkhof, A Fellgiebel, M Filippi, L Hausner, K Hauenstein, ... Journal of Neuroimaging 25 (5), 738-747, 2015 | 114 | 2015 |
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 112 | 2022 |
Basal forebrain and hippocampus as predictors of conversion to Alzheimer’s disease in patients with mild cognitive impairment–A multicenter DTI and volumetry study K Brüggen, M Dyrba, F Barkhof, L Hausner, M Filippi, PJ Nestor, ... Journal of Alzheimer's Disease 48 (1), 197-204, 2015 | 83 | 2015 |
New insights on the genetic etiology of Alzheimer’s and related dementia C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ... MedRxiv, 2020.10. 01.20200659, 2020 | 71 | 2020 |
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey M Bocchetta, S Galluzzi, PG Kehoe, E Aguera, R Bernabei, R Bullock, ... Alzheimer's & Dementia 11 (2), 195-206. e1, 2015 | 68 | 2015 |
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the European prospective DESCRIPA study M Damian, L Hausner, K Jekel, M Richter, L Froelich, O Almkvist, ... Dementia and geriatric cognitive disorders 36 (1-2), 1-19, 2013 | 58 | 2013 |
Progression of Alzheimer disease in Europe: data from the European ICTUS study B Vellas, L Hausner, L Frolich, C Cantet, V Gardette, E Reynish, S Gillette, ... Current Alzheimer Research 9 (8), 902-912, 2012 | 58 | 2012 |
Targeted mass spectrometry suggests beta-synuclein as synaptic blood marker in Alzheimer’s disease P Oeckl, S Halbgebauer, S Anderl-Straub, CAF von Arnim, ... Journal of proteome research 19 (3), 1310-1318, 2020 | 53 | 2020 |
Parallel atrophy of cortex and basal forebrain cholinergic system in mild cognitive impairment I Kilimann, L Hausner, A Fellgiebel, M Filippi, TJ Würdemann, H Heinsen, ... Cerebral cortex 27 (3), 1841-1848, 2017 | 46 | 2017 |
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease S Halbgebauer, P Oeckl, P Steinacker, D Yilmazer-Hanke, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (4), 349-356, 2021 | 43 | 2021 |